Lanx, Inc. Appoints Dan Gladney Chief Executive Officer
BROOMFIELD, Colo., Dec. 15, 2010 /PRNewswire/ -- Lanx, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, announced the appointment of Dan W. Gladney as Chief Executive Officer and as a member of the Board of Directors. He will assume the role on January 10, 2011. Gladney has more than 25 years of experience in the medical device industry, founding and leading companies in the orthopedic and cardiology sectors.
Dr. Jeffrey Thramann, Co-founder and Chairman, said, "The Board and the Lanx executive team are pleased to welcome Dan into this leadership position. His specific operating experience as Chief Executive of several emerging medical technology companies and public company experience makes him an ideal fit for our organization. We are confident he will make major contributions to the next stage of our growth and expansion."
Dan Gladney said, "I am excited to be joining the exceptional team here at Lanx as the company develops into a world-class spine company. The Company's dedication to surgeon driven innovation, impressive product portfolio, deep pipeline, and talented employees will continue to serve as a strong platform for growth and success. I look forward to working with the expanded team to bring innovative solutions to surgeons and patients."
Gladney was most recently Healthcare Operating Partner at Norwest Equity Partners (NEP) where he was responsible for strategic planning, business growth and corporate governance for NEP portfolio companies and evaluating and executing new investment opportunities for the firm.
Prior to joining NEP, Gladney served as President and CEO of several successful medical device companies, including DGIMED Ortho, Heart Leaflet Technologies and ACIST Medical Systems. He also served as Chairman, CEO and President of Compex Technologies, a publicly traded orthopedic and health and wellness electro therapy company.